ClinicalTrialsFinder

Biomarkers / Blood Clinical Trials in Jinan, Shandong

1 recruitingJinan, Shandong, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC

Neoadjuvant TherapyResectable Lung Non-Small Cell CarcinomaImmunotherapy+1 more
Shandong Cancer Hospital and Institute30 enrolled1 locationNCT06241807